The NPD is a CFTR biomarker capable of isolating CFTR activity, segregates patients based on CFTR function, is a recognized diagnostic test for CF, and has been a critical endpoint in early phase clinical trials of CFTR modulators [8]–[22]. The gene discussed is CFTR; the disease is cystic fibrosis.